These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
347 related articles for article (PubMed ID: 27852960)
1. Set and setting, psychedelics and the placebo response: An extra-pharmacological perspective on psychopharmacology. Hartogsohn I J Psychopharmacol; 2016 Dec; 30(12):1259-1267. PubMed ID: 27852960 [TBL] [Abstract][Full Text] [Related]
2. Psychedelics, placebo effects, and set and setting: Insights from common factors theory of psychotherapy. Gukasyan N; Nayak SM Transcult Psychiatry; 2022 Oct; 59(5):652-664. PubMed ID: 33499762 [TBL] [Abstract][Full Text] [Related]
3. Novel psychotherapeutics - a cautiously optimistic focus on Hallucinogens. Sherwood AM; Prisinzano TE Expert Rev Clin Pharmacol; 2018 Jan; 11(1):1-3. PubMed ID: 29224406 [No Abstract] [Full Text] [Related]
4. Self-Entropic Broadening Theory: Toward a New Understanding of Self and Behavior Change Informed by Psychedelics and Psychosis. Dourron HM; Strauss C; Hendricks PS Pharmacol Rev; 2022 Oct; 74(4):982-1027. PubMed ID: 36113878 [TBL] [Abstract][Full Text] [Related]
5. Advances in Behavioral Psychopharmacology. Sinn L Vet Clin North Am Small Anim Pract; 2018 May; 48(3):457-471. PubMed ID: 29415813 [TBL] [Abstract][Full Text] [Related]
9. A primer on caffeine pharmacology and its drug interactions in clinical psychopharmacology. Donovan JL; DeVane CL Psychopharmacol Bull; 2001; 35(3):30-48. PubMed ID: 12397877 [TBL] [Abstract][Full Text] [Related]
10. The neurobiology of psychedelic drugs: implications for the treatment of mood disorders. Vollenweider FX; Kometer M Nat Rev Neurosci; 2010 Sep; 11(9):642-51. PubMed ID: 20717121 [TBL] [Abstract][Full Text] [Related]
11. From Amrita to substance D: psychopharmacology, political economy, and technologies of the self. Kirmayer LJ; Raikhel E Transcult Psychiatry; 2009 Mar; 46(1):5-15. PubMed ID: 19293277 [No Abstract] [Full Text] [Related]
12. Why psychiatry needs psychedelics and psychedelics need psychiatry. Sessa B J Psychoactive Drugs; 2014; 46(1):57-62. PubMed ID: 24830186 [TBL] [Abstract][Full Text] [Related]
13. [Psychotherapeutic effects of psychotropic drugs: principle considerations from the psychobiologic viewpoint]. Langer G Wien Med Wochenschr; 1986 Oct; 136(19-20):491-7. PubMed ID: 3027996 [TBL] [Abstract][Full Text] [Related]
14. Psychedelic pleasures: An affective understanding of the joys of tripping. Bøhling F Int J Drug Policy; 2017 Nov; 49():133-143. PubMed ID: 28918193 [TBL] [Abstract][Full Text] [Related]
15. Moral Psychopharmacology Needs Moral Inquiry: The Case of Psychedelics. Langlitz N; Dyck E; Scheidegger M; Repantis D Front Psychiatry; 2021; 12():680064. PubMed ID: 34408677 [TBL] [Abstract][Full Text] [Related]
16. Novel psychoactive substances: the pharmacology of stimulants and hallucinogens. Schifano F; Papanti GD; Orsolini L; Corkery JM Expert Rev Clin Pharmacol; 2016 Jul; 9(7):943-54. PubMed ID: 26985969 [TBL] [Abstract][Full Text] [Related]
17. Applied human psychopharmacology: the practical psychobiological consequences of some novel and ancient psychoactive drugs. Parrott AC; Murphy P; Scholey AB Hum Psychopharmacol; 2012 Mar; 27(2):103-5. PubMed ID: 22389074 [No Abstract] [Full Text] [Related]
19. A protocol for the evaluation of new psychoactive drugs in man. Shulgin AT; Shulgin LA; Jacob P Methods Find Exp Clin Pharmacol; 1986 May; 8(5):313-20. PubMed ID: 3724306 [TBL] [Abstract][Full Text] [Related]
20. Head to head comparisons as an alternative to placebo-controlled trials. Vieta E; Cruz N Eur Neuropsychopharmacol; 2012 Nov; 22(11):800-3. PubMed ID: 22205018 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]